Results 171 to 180 of about 3,836,410 (303)

Suicide in patients with skin diseases: What to look out for? [PDF]

J Eur Acad Dermatol Venereol
Hrvatin Stancic B, Henning MAS, Jemec GBE.   +2 more
europepmc   +1 more source

Impact of Six‐Month Monitoring Compared to Three‐Month Monitoring of Laboratories During Methotrexate Therapy

Arthritis Care &Research, EarlyView.
Objective To evaluate whether extending the American College of Rheumatology–recommended monitoring interval for complete blood count and liver function tests in patients receiving methotrexate (MTX) affects timely detection of medication‐related toxicity.
Spencer Simko, Ray Zhang, Sohini Mukherjee, Puneet Bajaj, Bonnie L. Bermas   +4 more
wiley   +1 more source

Polyphenols as Multi-Target Regulators of Oxidative Stress, Mitochondrial Function, and Cell Survival Signaling in Skin Diseases. [PDF]

Int J Mol Sci
Cho MK, Choi MH, Kim KD, Park SQ, Lee SH, Nam HS, Lee YJ.   +6 more
europepmc   +1 more source

Caregiver Perspectives on the Burden of Disease and Treatment in Uncontrolled Gout

Arthritis Care &Research, EarlyView.
Objective Uncontrolled gout (UG) refers to persistently elevated serum urate (SU) levels >6 mg/dL and ongoing gout symptoms despite use of urate‐lowering therapy (ULT). The objective of this study was to evaluate the burden associated with informal caregiving for individuals with UG.
Angelo Gaffo, Bhavisha Desai, Abiola Oladapo, Nana Kragh, Rebekah Zincavage, Brad Padilla, Naomi Schlesinger   +6 more
wiley   +1 more source

Psoriasis and Skin Barrier

, 2017
The skin barrier is crucial for maintaining healthy skin by preventing loss of water and entrance of pathogenic microorganisms and irritants. Since disruption of the skin barrier induces keratinocyte proliferation, impaired barrier function is thought to
이시형
core  

The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics. [PDF]

Front Immunol
Zhang Y, Shi Z, Mo X, Ju Q, Pan Z.
europepmc   +1 more source

Employment Trajectories of Patients With Systemic Lupus Erythematosus and Factors Driving Transitions Between States

Arthritis Care &Research, EarlyView.
Objective Systemic lupus erythematosus (SLE) significantly impacts employment capacity. This study aimed to investigate the impact of burden of disease activity, damage, and treatment on employment outcomes and transitions in patients with SLE. Methods Using data from a single center, we analyzed employment transitions, adjusted mean disease activity ...
Javier Mencia‐Ledo, Zahi Touma, Laura Whittall Garcia, Dafna D. Gladman, Behdin Nowrouzi‐Kia   +4 more
wiley   +1 more source

Clinical outcomes and prognostic factors of pemphigus vulgaris and pemphigus foliaceus: A 20-year retrospective study

Chinese Medical Journal
Hongda Li, Wenchao Li, Zhenzhen Wang, Shan Cao, Pengcheng Huai, Tongsheng Chu, Baoqi Yang, Yonghu Sun, Peiye Xing, Guizhi Zhou, Yongxia Liu, Shengli Chen, Qing Yang, Mei Wu, Zhongxiang Shi, Hong Liu, Furen Zhang, Lishao Guo   +17 more
doaj   +1 more source

Optimizing Hydroxychloroquine Blood Levels and Long‐Term Hydroxychloroquine Intake Could Lower Atherosclerotic Cardiovascular Disease Risk and Prevent Polypharmacy in Systemic Lupus Erythematosus

Arthritis Care &Research, EarlyView.
Objective Hydroxychloroquine (HCQ) is the cornerstone of systemic lupus erythematosus (SLE) management with benefits extending beyond SLE control, including protection against atherosclerotic cardiovascular disease (ASCVD). Although HCQ blood levels reflect recent exposure and long‐term intake reflects medication adherence, the impact of longitudinal ...
Shivani Garg, Murray Urowitz, Charlie Dentz, Niriti Adhikari, Fauzia Hollnagel, Nathalie Costedoat‐Chalumeau   +5 more
wiley   +1 more source

Editorial: Type 2 inflammatory skin diseases: novel therapies and clinical insights. [PDF]

Front Med (Lausanne)
Li L.
europepmc   +1 more source